AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,822
Total Value
$77,601.44
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common stock | โ | Jan 5, 2026 | Exercise/Conversion | 8,475 | $0.00 | $0.00 | 37,665 | Direct | โ | View Details | |
Chief Commercial Officer | Common stock | โ | Jan 5, 2026 | Sale | 2,872 | $27.02 | $77,601.44 | 34,793 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted stock units | Derivative | Jan 5, 2026 | Exercise/Conversion | 8,475 | $0.00 | $0.00 | 0 | Direct | โ | View Details |